- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- Resource Center
- PKD & Rare Kidney Diseases
- Anemia Due To CKD
- CKD & Related Comorbid Conditions
- Kidney Failure & Kidney Replacement Therapies
- Electrolyte Disorders
- NephU Nutrition & The NephChefTM
In this Part 1 of a 3 Part series, we will briefly describe the pathophysiology of Autosomal Dominant Polycystic Kidney Disease (ADPKD) including its cellular, metabolic, and systemic impact. Then, we will discuss the nutritional/diet management strategies for ADPKD, with an emphasis on using the Ketogenic Diet. We will set the stage for Part 2, describing a Plant-Focused Ketogenic Diet Program for improved ADPKD outcomes.
*Dr Richard (Rick) Lindquist is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Laura Frank is an employee of OPDC.
Richard Lindquist Consulting, PLLC*
Dr Richard Lindquist is a board-certified Obesity Medicine and Family Medicine physician who graduated from the University of Washington and completed his residency at Bayfront Medical Center in Florida. Dr Lindquist is former Medical Program Director of Swedish Weight Loss Services in Seattle and former Medical Director for Providence St. Joseph Health System’s Health Weight Initiative. He is currently a consultant to hospitals and health care systems, assisting with weight management program planning, development, training, and education.
Dr Lindquist is actively involved in state and national organizations and has earned numerous awards and recognitions for his work, including the Obesity Medicine Association’s “Bariatrician of the Year” for his contributions in advancing the field of bariatric medicine. He is a Board member of the American Board of Obesity Medicine and is the WA State Representative of the Obesity Society and the Obesity Medicine Association for “Access to Care.” Current hot topic projects include Obesity in Renal disease, Ketosis in health and disease, and work on an upcoming book on The Ideal Bariatric Center: Developing and Maintaining the Modern Metabolic and Bariatric Program.
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Laura Frank is a Medical Science Liaison (MSL) working in the nephrology space for Otsuka Pharmaceutical Development and Commercialization (OPDC). Dr Frank holds a PhD in exercise physiology, a MPH in epidemiology, a M.Ed in Nutrition & Dietetics, a BS in molecular biology and is a Registered Dietitian Nutritionist (RDN). She brings a clinical background to the field through her experiences as an acute-care clinical dietitian working with patients with renal diseases and related conditions. She also has a strong academic background with over 12 years of teaching experience and over 6 years of postdoctoral research. She has held several leadership positions such as director of clinical sites for Washington State University’s graduate program in Nutrition & Exercise Physiology and program manager for several projects and grants associated with healthcare organizations. She also has an interest in and holds a professional certificate in Health Economics and Outcomes Research (HEOR), with experience in projects related to quality measures.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.May 2020 MRC2.CORP.X.04767
September 28 from 12:00 pm to 1:00 pm
September 28 from 6:00 pm to 7:00 pm
September 28 from 9:00 pm to 10:00 pm
- Resource Center
- Presentation Request